Clinical trial

Stem Cell Derived Exome for Treatment of Diabetic Foot

NCT06480123

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2024-08-01

PhasePHASE1 / PHASE2

Study timeline

Study start (estimated)2024-08-01Date precision: day

Registry last updated2024-06-28

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetic Footunresolved

Stem Cellunresolved

Interventions

Skin drug prepared with exome originated from stem cellDRUG

Sponsors & collaborators

Second Affiliated Hospital of Guangzhou Medical Universitylead sponsor

Mapped research locations

GuangzhouGuangdong, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06480123 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.